1. Roose, J. et al. High expression of the HMG box factor sox-13 in arterial walls during embryonic development. Nucleic acids research. 1998, 26(2):469-476.
2. Roose, J. et al. The Sox-13 Gene: Structure, Promoter Characterization, and Chromosomal Localization. Genomics. 1999, 57(2):301-305.
3. Kasimiotis H. et al. Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes. 2000, 49(4): 555-561.
4. Schepers, G.E., R.D. Teasdale, and P. Koopman. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Developmental cell, 2002. 3(2): p. 167-170.
5. Graves, J.A.M. Two uses for old SOX. Nature genetics. 1997, 16(2):114.
6. Fida S et al. Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases. Journal of autoimmunity. 2002, 19(4):251-257.
7. Kasimiotis H et al. Antibodies to SOX13 (ICA12) are associated with type 1 diabetes. Autoimmunity. 2001, 33(2):95-101.
8. Argentaro A et al. Linkage studies of SOX13, the ICA12 autoantigen gene, in families with type 1 diabetes. Molecular genetics and metabolism. 2001, 72(4):356-359.
9. Bieg S, J. Seissler, and W.A. Scherbaum. Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes. Medizinische Klinik (Munich, Germany: 1983). 1995, 90(10):594-598.
10. Wilkin T.J. Autoantibodies as mechanisms, markers, and mediators of B‐cell disease. Diabetes/metabolism reviews. 1991, 7(2):105-120.
11. Lucassen A.M. et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nature genetics. 1993, 4(3):305.
12. Rabin D.U. et al. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 1992, 41(2):183-186.
13. Wildner G, Kaufmann U. What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells. Autoimmun Rev. 2013, 12 (11):1070-1075
14. Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller JF, Wesley JD et al. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun. 2004, 50:77-82
15. Han S, Donelan W, Wang H, Reeves W, Yang LJ, Novel autoantigens in type 1 diabetes. Am J Transl Res. 2013, 5(4):379-392
16. Organization, W.H., Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. 1999, Geneva: World health organization.
17. SHTAUVERE‐BRAMEUS, A., et al., Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients. Annals of the New York Academy of Sciences. 2002, 958(1):297-304.
18. Elkon, K. and P. Casali, Nature and functions of autoantibodies. Nature Reviews Rheumatology. 2008, 4(9):491.
19. Bosi, E. and E. Bonifacio. Autoantibodies in insulin-dependent diabetes mellitus. Journal of endocrinological investigation. 1994, 17(7):521-531.
20. Pi-Sunyer, F.X. Medical hazards of obesity. Annals of internal medicine, 1993, 119:655-660.
21. Willis J.A. et al. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. Diabetes research and clinical practice. 1996, 33(2):89-97.
22. Lernmark Å. Glutamic acid decarboxylase–gene to antigen to disease. Journal of internal medicine. 1996, 240(5):259-277.
23. Bonifacio E. et al. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. The Journal of Immunology, 1995. 155(11): 5419-5426.
24. Falorni, A. et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia, 1996. 39(9): 1091-1098.
25. Sanjeevi C. et al. Glutamic acid decarboxylase (GAD) in insulin-dependent diabetes mellitus. Diabetes Nutrition and Metabolism. 1996, 9:167-182.
26. Christgau S. et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. The Journal of cell biology. 1992, 118(2):309-320.
27. Solimena, M. et al. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. The EMBO journal. 1996, 15(9):2102-2114.
28. Pevny, L.H. and R. Lovell-Badge. Sox genes find their feet. Current opinion in genetics & development. 1997, 7(3):338-344.
29. Hagopian W.A et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. The Journal of clinical investigation. 1993, 91(1):368-374.
30. Sanjeevi C et al. HLA and glutamic acid decarboxylase in human insulin‐dependent diabetes mellitus. Diabetic medicine, 1996. 13(3): p. 209-217.
31. Sanjeevi C. et al. Prevalence of GAD65 autoantibodies in South Indian patients with insulin-dependent diabetes mellitus, and in their parents. Diabetes, nutrition & metabolism. 1997, 10(2):60-64.
32. Hyoty H and Taylor KW, The role of viruses in human diabetes. Diabetologia. 2002, 45 (10):1353-1361
33. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. Aug 2000, 49(8):1319-1324
34. Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A et al. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulindependent Diabetes Registry. Diabet Med J Br Diabet Assoc, Jun 2012, 29:761-766
35. Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J, Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia. May 2008, 51(5):769-772
36. Blank M, Barzilai O, Shoenfeld Y, Molecular mimicry and auto-immunity. Clin Rev Allergy Imunol. Feb 2007, 32(1):111-118
37. Coppieters KT, Wiberg A, von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. APMIS. 2012, 120(12):941-949